| A novel approach for clustering proteomics data using Bayesian fast Fourier transform. |
15769836 |
Bioinformatics |
| A novel approach toward development of a rapid blood test for breast cancer. |
14499014 |
Clin Breast Cancer |
| Age influences on the molecular presentation of tumours. |
35017538 |
Nat Commun |
| Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. |
17981926 |
Clin Chem |
| Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome. |
40894632 |
bioRxiv |
| Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. |
16552720 |
J Cell Biochem |
| ApplyPolygenicScore: An R package for applying polygenic risk score models. |
41488031 |
Genet Med Open |
| Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. |
12324514 |
Clin Chem |
| Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate. |
29330297 |
Mol Cancer Res |
| Clinical proteomics: A need to define the field and to begin to set adequate standards. |
21136664 |
Proteomics Clin Appl |
| Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer. |
39547899 |
Eur Urol Oncol |
| Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. |
14997503 |
Proteomics |
| Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine. |
38580319 |
|
| Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction. |
38862616 |
Nat Biotechnol |
| Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data. |
12762451 |
Biometrics |
| Data-driven identification of inherent features of eukaryotic stress-responsive genes. |
35265837 |
NAR Genom Bioinform |
| Deconvolution filters to enhance resolution of dense time-of-flight survey spectra in the time-lag optimization range. |
16636999 |
Rapid Commun Mass Spectrom |
| Defining the role of mass spectrometry in cancer diagnostics. |
15466969 |
Cancer Epidemiol Biomarkers Prev |
| Deletions Rate-Limit Breast and Ovarian Cancer Initiation. |
39484366 |
bioRxiv |
| Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. |
11290567 |
Am J Pathol |
| Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. |
18043497 |
Laryngoscope |
| Direct N-Glycosylation Profiling of Urine and Prostatic Fluid Glycoproteins and Extracellular Vesicles. |
34646811 |
Front Chem |
| Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction. |
31434495 |
Arterioscler Thromb Vasc Biol |
| Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques. |
15550476 |
Clin Chem |
| Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. |
35697807 |
Nat Biotechnol |
| Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. |
15613711 |
Clin Chem |
| Expression of genes and proteins specific for prostate cancer. |
15535438 |
J Urol |
| Feature extraction in the analysis of proteomic mass spectra. |
16502467 |
Proteomics |
| Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. |
34724198 |
Cancer |
| Functional clustering algorithm for high-dimensional proteomics data. |
16046812 |
J Biomed Biotechnol |
| Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay. |
10833385 |
Protein Expr Purif |
| Identification of non-canonical peptides with moPepGen. |
38585946 |
bioRxiv |
| Identification of non-canonical peptides with moPepGen. |
40523945 |
Nat Biotechnol |
| Identification of patients with head and neck cancer using serum protein profiles. |
14732777 |
Arch Otolaryngol Head Neck Surg |
| iSubGen generates integrative disease subtypes by pairwise similarity assessment. |
39447572 |
Cell Rep Methods |
| Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. |
16760258 |
Mol Cell Proteomics |
| Measurement reproducibility in the early stages of biomarker development. |
15665389 |
Dis Markers |
| Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis. |
35437583 |
Cancer Epidemiol Biomarkers Prev |
| Mining the low molecular weight proteome of blood. |
21136732 |
Proteomics Clin Appl |
| Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer. |
39294048 |
Eur Urol |
| Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. |
37126232 |
J Urol |
| National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. |
18606634 |
Clin Chem |
| NFTest: automated testing of Nextflow pipelines. |
38341660 |
Bioinformatics |
| Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. |
12171882 |
Clin Cancer Res |
| Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range. |
17918874 |
J Proteome Res |
| Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis. |
35119778 |
J Extracell Vesicles |
| Overexpression of alpha-defensin is associated with bladder cancer invasiveness. |
16520271 |
Urol Oncol |
| Perish and publish: Dynamics of biomedical publications by deceased authors. |
36103484 |
PLoS One |
| Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. |
15112261 |
Cancer |
| PipeVal: light-weight extensible tool for file validation. |
38341658 |
Bioinformatics |
| promor: a comprehensive R package for label-free proteomics data analysis and predictive modeling. |
36922981 |
Bioinform Adv |
| Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy. |
36097168 |
Prostate Cancer Prostatic Dis |
| Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review. |
33093161 |
Cancer Epidemiol Biomarkers Prev |
| Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes. |
38871730 |
Nat Commun |
| Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture. |
36108240 |
Cancer Discov |
| Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. |
38049604 |
Nat Cell Biol |
| Protein profiling in urine for the diagnosis of bladder cancer. |
15277356 |
Clin Chem |
| Proteomic approaches to biomarker discovery in prostate and bladder cancers. |
11721637 |
Proteomics |
| Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. |
11708463 |
Ann N Y Acad Sci |
| Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry. |
34453155 |
Nat Rev Urol |
| Proteomic strategies for biomarker identification: progress and challenges. |
11249741 |
Curr Opin Mol Ther |
| Proteomics in early detection of cancer. |
11568117 |
Clin Chem |
| Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. |
11507047 |
Cancer Res |
| Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence Variants. |
34680183 |
Cancers (Basel) |
| Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling. |
16637003 |
Rapid Commun Mass Spectrom |
| RNA transcripts serve as a template for double-strand break repair in human cells. |
40348775 |
Nat Commun |
| SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression. |
17705230 |
Prostate |
| SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. |
15726646 |
Hepatology |
| SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. |
18024530 |
Clin Chem |
| SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. |
15258337 |
Dis Markers |
| Selective capture of prostatic basal cells and secretory epithelial cells for proteomic and genomic analysis. |
15283892 |
Urol Oncol |
| Serum biomarkers to differentiate benign and malignant mammographic lesions. |
17481542 |
J Am Coll Surg |
| Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. |
15709174 |
Clin Cancer Res |
| Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. |
15258333 |
Dis Markers |
| Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. |
12097261 |
Cancer Res |
| Serum protein profiles to identify head and neck cancer. |
15014013 |
Clin Cancer Res |
| Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. |
15723595 |
Expert Rev Mol Diagn |
| Sex Differences in Cancer Functional Genomics: Gene Dependency and Drug Sensitivity. |
39975298 |
bioRxiv |
| Sex Differences in the Cancer Proteome. |
40166173 |
bioRxiv |
| Signal detection in high-resolution mass spectrometry data. |
18173224 |
J Proteome Res |
| Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells. |
36061737 |
ACS Omega |
| Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. |
15383419 |
Ann Surg Oncol |
| Targeted Mass Spectrometry of a Clinically Relevant PSA Variant from Post-DRE Urines for Quantitation and Genotype Determination. |
32614141 |
Proteomics Clin Appl |
| Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer. |
39184453 |
BJC Rep |
| The "omics" haystack: defining sources of sample bias in expression profiling. |
16120944 |
Clin Chem |
| The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. |
36251389 |
Cancer Res |
| The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology. |
15283893 |
Urol Oncol |
| The Germline and Somatic Origins of Prostate Cancer Heterogeneity. |
39945744 |
Cancer Discov |
| The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancer. |
40128621 |
Nat Genet |
| The Landscape of Prostate Tumour Methylation. |
39990314 |
bioRxiv |
| The Proteogenomics of Prostate Cancer Radioresistance. |
39166898 |
Cancer Res Commun |
